Form D · Biotechnology
MYRIAD GENETICS INC
Salt Lake City, UT · CIK 0000899923
Offering snapshot reported Feb 12, 2019 · SEC filing
- Reported sold
- $249K Offering amount: $249K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 4, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 1
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 12, 2019 | Amendment | $249,390 | No comparison | 1 | SEC filing |
| Nov 14, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-298722
Source: Form D, filed Feb 12, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lawrence C. Best | Director |
| Mark C. Capone | Director, Executive |
| Helner Dreismann | Director |
| Alexander Ford | Executive |
| Walter Gilbert | Director |
| John T. Henderson | Director |
| Gary A. King | Executive |
| Jerry S. Lanchbury | Executive |
| Dennis Langer | Director |
| Richard Marsh | Executive |
| Ralph L. Mc Dade | Executive |
| S. Louise Phanstiel | Director |
| Richard Bryan Riggsbee | Executive |
| W. Lloyd Sanders | Executive |
| Bernard F. Tobin | Executive |
| Mark Verratti | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
320 Wakara Way
Salt Lake City, UT, 84108
Salt Lake City, UT, 84108